Schott Pharma Ag & CO Kgaa (1SXP.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2020 | |
| Sales | 584,229 |
| Cost of Goods | 388,221 |
| Gross Profit | 196,008 |
| Operating Expenses | 104,399 |
| Operating Income | 91,609 |
| Interest Expense | 1,920 |
| Other Income | 5,607 |
| Pre-tax Income | 95,296 |
| Income Tax | 17,669 |
| Net Income Continuous | 77,627 |
| Minority Interests | -147 |
| Net Income | $77,480 |
| EPS Basic Total Ops | 0.51 |
| EPS Diluted Total Ops | 0.51 |
| EBITDA(a) | $130,944 |